Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Abetimus:

Search results

Items: 1 to 20 of 22

  • Filters activated: Cancer. Clear all to show 57 items.
1.

Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.

Furie R, Toder K, Zapantis E.

Semin Nephrol. 2015 Sep;35(5):509-20. doi: 10.1016/j.semnephrol.2015.08.012. Review.

PMID:
26573553
2.

B cell suppression in primary glomerular disease.

Rood IM, Hofstra JM, Deegens JK, Wetzels JF.

Adv Chronic Kidney Dis. 2014 Mar;21(2):166-81. doi: 10.1053/j.ackd.2014.01.005. Review.

PMID:
24602466
3.

Novel biological treatments for systemic lupus erythematosus: current and future modalities.

Bezalel S, Asher I, Elbirt D, Sthoeger ZM.

Isr Med Assoc J. 2012 Aug;14(8):508-14. Review.

4.

Current and novel therapeutics in the treatment of systemic lupus erythematosus.

Yildirim-Toruner C, Diamond B.

J Allergy Clin Immunol. 2011 Feb;127(2):303-12; quiz 313-4. doi: 10.1016/j.jaci.2010.12.1087. Review.

5.

Treatment of lupus nephritis: facing the era of immunotherapy.

Aran AA, Putterman C.

Panminerva Med. 2008 Sep;50(3):235-45. Review.

PMID:
18927528
6.

Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.

Navaneethan SD, Viswanathan G, Strippoli GF.

Drugs. 2008;68(15):2095-104. Review.

PMID:
18840001
7.

Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.

Cardiel MH, Tumlin JA, Furie RA, Wallace DJ, Joh T, Linnik MD; LJP 394-90-09 Investigator Consortium.

Arthritis Rheum. 2008 Aug;58(8):2470-80. doi: 10.1002/art.23673.

8.

Novel therapies in lupus - focus on nephritis.

Cordeiro AC, Isenberg DA.

Acta Reumatol Port. 2008 Apr-Jun;33(2):157-69. Review.

9.

B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data.

Hawker K.

Curr Opin Neurol. 2008 Apr;21 Suppl 1:S19-25. doi: 10.1097/01.wco.0000313360.38306.ab. Review.

PMID:
18388796
10.

Novel therapies of lupus nephritis.

Schieppati A, Remuzzi G.

Curr Opin Nephrol Hypertens. 2008 Mar;17(2):156-61. doi: 10.1097/MNH.0b013e3282f4e54d. Review.

PMID:
18277148
11.

The biology behind the new therapies for SLE.

Ermann J, Bermas BL.

Int J Clin Pract. 2007 Dec;61(12):2113-9. Review.

PMID:
17997810
12.

Exploring new territory: the move towards individualised treatment.

Haubitz M.

Lupus. 2007;16(3):227-31. Review.

PMID:
17432112
13.

[Progress and perspectives in the treatment of systemic lupus erythematosus].

Robak E, Sysa-Jedrzejowska A, Wozniacka A.

Przegl Lek. 2005;62(9):894-9. Review. Polish.

PMID:
16541725
14.

Gateways to clinical trials.

Bayes M, Rabasseda X, Prous JR.

Methods Find Exp Clin Pharmacol. 2004 Sep;26(7):587-612. Review.

PMID:
15538546
15.

Gateways to clinical trials.

Bayes M, Rabasseda X, Prous JR.

Methods Find Exp Clin Pharmacol. 2003 May;25(4):317-40.

PMID:
12808477
16.

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.

Alarcón-Segovia D, Tumlin JA, Furie RA, McKay JD, Cardiel MH, Strand V, Bagin RG, Linnik MD, Hepburn B; LJP 394 Investigator Consortium.

Arthritis Rheum. 2003 Feb;48(2):442-54.

17.

[New prospects for the treatment of systemic lupus erythematosus].

Iniestra Flores F, Orea Solano M.

Rev Alerg Mex. 2002 Nov-Dec;49(6):176-80. Review. Spanish.

PMID:
12561649
18.

[Lupus nephritis: treatments for today and tomorrow].

de Frutos MA.

Nefrologia. 2001;21(6):522-3. Spanish. No abstract available.

19.

Current and emerging lupus treatments.

Wallace D.

Am J Manag Care. 2001 Oct;7(16 Suppl):S490-5. Review.

20.

Advances in the treatment of lupus nephritis.

Zimmerman R, Radhakrishnan J, Valeri A, Appel G.

Annu Rev Med. 2001;52:63-78. Review.

PMID:
11160768

Supplemental Content

Loading ...
Support Center